Singh and colleagues presented preliminary evidence that a mutation in the SCN9A gene may act as a genetic modifier of Dravet syndrome when found in conjunction with an SCN1A mutation (Singh et al., 2009). This evidence concerns the gene SCN1A and encephalopathy, progressive, early-onset, with brain edema and/or leukoencephalopathy.